, Will stock surge before Earnings results? NASDAQ:CDXC, NASDAQ:MVIS, NASDAQ:ADMA, NASDAQ:CNTY

CHROMADEX (NASDAQ:CDXC) EARNINGS INFORMATION (NASDAQ:CDXC)

ChromaDex last issued its earnings results on March 9th, 2021. The reported ($0.10) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.01. ChromaDex has generated ($0.52) earnings per share over the last year. ChromaDex has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, May 10th, 2021 based off prior year’s report dates.

IS CHROMADEX A BUY RIGHT NOW? (NASDAQ:CDXC)

3 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for ChromaDex in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” ChromaDex stock.
ChromaDex

MICROVISION (NASDAQ:MVIS) EARNINGS INFORMATION (NASDAQ:MVIS)

MicroVision last posted its earnings results on March 11th, 2021. The electronics maker reported ($0.02) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.02). The business had revenue of $0.40 million for the quarter, compared to the consensus estimate of $0.41 million. Its revenue for the quarter was down 91.4% on a year-over-year basis. MicroVision has generated ($0.24) earnings per share over the last year. MicroVision has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, May 6th, 2021 based off prior year’s report dates.

IS MICROVISION A BUY RIGHT NOW? (NASDAQ:MVIS)

2 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for MicroVision in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” MicroVision stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MVIS, but not buy additional shares or sell existing shares.
MicroVision

ADMA BIOLOGICS EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:ADMA)

IS ADMA BIOLOGICS A BUY RIGHT NOW? (NASDAQ:ADMA)

4 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for ADMA Biologics in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” ADMA Biologics stock.
ADMA Biologics

CENTURY CASINOS EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:CNTY)

IS CENTURY CASINOS A BUY RIGHT NOW? (NASDAQ:CNTY)

2 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Century Casinos in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Century Casinos stock.
Century Casinos